Results 261 to 270 of about 30,272 (291)

Avoiding CAR-NK cell fratricide

Nature Cancer, 2022
openaire   +2 more sources

Critical care management of chimeric antigen receptor T‐cell therapy recipients

Ca-A Cancer Journal for Clinicians, 2022
Alexander Shimabukuro-Vornhagen, Boris Böll, Peter Schellongowski   +2 more
exaly  

Chimeric antigen receptor T‐cell therapy in multiple myeloma: A comprehensive review of current data and implications for clinical practice

Ca-A Cancer Journal for Clinicians, 2023
Rujul Parikh, Sagar Lonial
exaly  

Long-term outcomes following CAR T cell therapy: what we know so far

Nature Reviews Clinical Oncology, 2023
James N Kochenderfer
exaly  

Prostate Cancer: CAR-NK or Ab

2023
openaire   +1 more source

CAIX-specific CAR-NK targeting renal cell carcinoma

European Urology, 2022
J.C. Oosterwijk-Wakka, J.Y. Xu, M.C.A. De Weijert, A.N. Kenyon, P.K.J.D. De Jonge, H. Dolstra, P.F.A. Mulders, E. Oosterwijk   +7 more
openaire   +1 more source

Overcoming on-target, off-tumour toxicity of CAR T cell therapy for solid tumours

Nature Reviews Clinical Oncology, 2022
Christian Luca Flugel, Robbie G Majzner, Giedre Krenciute   +2 more
exaly  

Immunogenicity of CAR T cells in cancer therapy

Nature Reviews Clinical Oncology, 2021
Dimitrios L Wagner, Michael A Pulsipher, Nabil M Ahmed   +2 more
exaly  

Preparing for CAR T cell therapy: patient selection, bridging therapies and lymphodepletion

Nature Reviews Clinical Oncology, 2022
Leila Amini, Nirali N Shah, Shannon L Maude   +2 more
exaly  

Recent advances and discoveries in the mechanisms and functions of CAR T cells

Nature Reviews Cancer, 2021
Rebecca C Larson, Marcela V Maus
exaly